Here we present the results of a genome-wide CRISPR screen aiming to identify the key molecules that regulate the critical initial step in the formation of the MS lesion: the infiltration of autoreactive CD4+ T cells from the blood to the CNS. This evidence concerns the gene CD4 and myeloid sarcoma.